Skip to Main Content

Try STAT+ TODAY

vision

Most Read

Eye - for spark

Biotech By Matthew Herper

Safety concerns regarding Novartis’ new eye drug boost Regeneron stock

In the Lab By Sharon Begley

Scientists show mice an Orson Welles movie, then disprove dogma about how vision works

Eye close up

Health Tech By Lauren Joseph

5 burning questions about using artificial intelligence to prevent blindness

polarized RPE monolayer on a biodegradable scaffold

In the Lab By Sharon Begley

Macular degeneration trial will be first human test in U.S. of Nobel-winning stem cell technique

macular degeneration

Biotech By Robert Weisman — Boston Globe

Research into new macular degeneration treatments takes off as cases steadily rise

In the Lab By Casey Ross

Opening the ‘black box,’ Google DeepMind AI system diagnoses eye diseases and shows its work

Andrew Huberman 05

In the Lab By Rebecca Robbins

A daredevil researcher’s latest quest: to restore sight lost to glaucoma using virtual reality

Amish Clinic

Special Report By Eric Boodman

The Amish pool resources for their medical care. A budget-busting gene therapy puts them in a bind

All Coverage

covid 19 testing sign

First Opinion By Bonnielin Swenor

Dearth of disability-related Covid-19 data can confound response efforts

ophthalmologist with patient

Health Tech By Casey Ross

Google develops AI to identify patients at high risk of blindness

advertisement

Genetic Frontiers Gene Editing Blindness

In the Lab By Associated Press

In its first use inside the human body, CRISPR genome editing tested as blindness therapy

Novartis campus

Pharmalot By Ed Silverman

Novartis employee claims she was fired for complaining about incorrect data

Close up of an eye

In the Lab By Orly Nadell Farber

Glaucoma may be an autoimmune disease, study finds, suggesting new treatment approaches

Close-up eye

In the Lab By Andrew Joseph

Early trials of stem-cell therapies hint at potential to restore some vision

Rods and cones photoreceptors

In the Lab By Sharon Begley

A CRISPR trick in blind mice points the way to possible treatments for inherited diseases

Three vials

Biotech By Andrew Joseph

At $850,000, price for new childhood blindness gene therapy four times too high, analysis says

University of Nevada

Health By Rebecca Robbins

‘What the 21st century demands’: designing homes to improve patients’ health

Alma's Sun Bath

Health By Leah Samuel

5 beauty-enhancing gadgets throughout history that were terrible ideas

Autism Google Glass

Health By Charles Piller

Google Glass is back — as a tool to coach autistic children, train doctors, and more

Boddities By Megan Thielking

Watch: Episode 12: What would happen to your eyes if you looked at the solar eclipse?

Medical Mystery: B2

Medical Mystery By Allison Bond

This 6-year-old suddenly had trouble reading. Why was she going blind?

Boddities By Megan Thielking

How well do you know your body? Take our quiz

Medical Mystery By Allison Bond

When eye irritation is more than it seems at first glance

Kapil Bharti

In the Lab By Andrew Joseph

Q&A: Turning to stem cells to restore vision

Blind tadpole

In the Lab By Eric Boodman

Transplanted eyes let tadpoles see through their tails

NEJM Eye

Health By Sharon Begley

Three patients blinded by stem cell procedure, physicians say

eye surgery blurry vision

Health By Associated Press

New help for that bane of middle age: blurry close-up vision

Novartis campus

Business By Charles Piller

Autofocus contact lens being developed by Verily and Alcon suffers delay